A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.

NCT03281876 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

606

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Disorders

Interventions

BIOLOGICAL: NTHi Mcat investigational vaccine (GSK3277511A)
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline